Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4837280

Clc1cccc(CNCCOc2ccc(-c3nc4cc(Br)cnc4[nH]3)cc2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
ADRA1D P25100 1/20 0.38
DRD2 P14416 2/20 0.38
DRD3 P35462 2/20 0.38
DRD4 P21917 1/20 0.38
CASR P41180 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GID4 Q8IVV7 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5256661 0.93 ADRA1D (0.41) CDK4CCND1ADRA1DDRD2DRD3
Trifluoroacetic Acid SCHEMBL4842803 0.92 KMT2A (0.45) DRD4KMT2AMEN1HDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4842215 0.91 HDAC6 (0.41) DRD2DRD3DRD4KMT2AMEN1
Trifluoroacetic Acid SCHEMBL4843769 0.90 KMT2A (0.43) CASRKMT2AMEN1HDAC3HDAC4
Trifluoroacetic Acid SCHEMBL4844087 0.88 MEN1 (0.51) CDK4CCND1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL4840541 0.88 HTR5A (0.42) DRD2DRD3DRD4KMT2AHDAC3
Trifluoroacetic Acid SCHEMBL4844131 0.87 HDAC6 (0.39) DRD4KMT2AHDAC3HDAC4HDAC1
Trifluoroacetic Acid SCHEMBL4840737 0.86 HDAC6 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL4839090 0.86 GPR6 (0.43) CDK4CCND1HDAC3HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL4835096 0.85 TAAR1 (0.48) DRD2DRD3DRD4KMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 CDK4 289/4885CCND1 574/4885ADRA1D 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.